The challenges of diagnosis and management of Gitelman syndrome. (6th October 2019)

• Record Type: Journal Article
• Authors: Urwin, Stephanie; Willows, Jamie; Sayer, John A.
• Is Part Of: Clinical endocrinology. Volume 92:Number 1(2020)
• Page Start: 3
• Page End: 10
• Publication Date: 2019-10-06
• Subjects: Gitelman syndrome -- hypokalaemia -- metabolic alkalosis -- renal salt wasting; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1111/cen.14104
• Languages: English
• ISSNs: 0300-0664

Abstract

Abstract: Gitelman syndrome is an inherited tubulopathy characterized by renal salt wasting from the distal convoluted tubule. Defects in the sodium chloride cotransporter (encoded by SLC12A3 ) underlie this autosomal recessive condition. This article focuses on the specific challenges of diagnosing and treating Gitelman syndrome, with use of an illustrative case report. Symptoms relate to decreased serum potassium and magnesium levels, which include muscle weakness, tetany, fatigue and palpitations. Sudden cardiac deaths have been reported. Making a diagnosis may be difficult given its rarity but is important. A knowledge of the serum and urine biochemical picture is vital to distinguish it from a broad differential diagnosis, and application of genetic testing can resolve difficult cases. There is a group of Gitelman syndrome heterozygous carriers that experience symptoms and electrolyte disturbance and these patients should be managed in a similar way, though here genetic investigations become key in securing a difficult diagnosis. Potassium and magnesium replacement is the cornerstone of treatment, though practically this can be hard for patients to manage and often does not fully relieve symptoms even when serum levels are normalized. Challenges arise due to the lack of randomized controlled trials focussing on treatment of this rare disease; hence, clinicians endorse strategies in line with correction of the underlying pathophysiology such as sodium loading or pharmacological treatments, which seem to help some patients. Focussed dietary advice and knowing the best tolerated preparations of potassium and magnesium medications are useful tools for the physician, as well as an awareness of the specific burdens that this patient group face in order to signpost appropriate support.